GlassScriptPhysician profile
Kent Tegeler
NPI 1760481139
$2,158.43
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $303 · 2021: $471 · 2022: $361 · 2023: $457 · 2024: $16.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $370.92 | 2019-2023 | |
| Abbvie INC. | $291.84 | 2019-2023 | Lo Loestrin Fe |
| Amgen INC. | $192.31 | 2019-2022 | |
| Coopersurgical, INC. | $189.91 | 2019-2022 | |
| Astellas Pharma US INC | $175.53 | 2019-2024 | Veozah, Myrbetriq |
| Intuitive Surgical, INC. | $143.17 | 2019-2020 | |
| Channel Medsystems, INC. | $139.33 | 2022-2023 | |
| Therapeuticsmd, INC. | $91.48 | 2021-2022 | |
| Ethicon US, LLC | $85.71 | 2020 | |
| Medtronic, INC. | $68.06 | 2021 | |
| Allergan, INC. | $67.11 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $62.19 | 2021-2023 | |
| Organon LLC | $60.06 | 2021-2023 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $45.38 | 2020-2023 | |
| Pacira Pharmaceuticals Incorporated | $32.10 | 2023 | Exparel |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $26.90 | 2021-2022 | |
| Avion Pharmaceuticals | $25.13 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $16.60 | 2023 | Myfembree |
| Boston Scientific Corporation | $14.05 | 2019 | |
| Minerva Surgical, INC | $14.02 | 2019 | |
| Bsn Medical INC | $12.34 | 2019 | |
| Lupin INC. | $11.73 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.56 | 2020 | |
| Covidien LP | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Tegeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.